American College of Cardiology launches new STS/ACC TAVR In-Hospital Mortality Risk App

NewsGuard 100/100 Score

The American College of Cardiology has launched a new STS/ACC TAVR In-Hospital Mortality Risk App and an extensively overhauled the ACC AnticoagEvaluator App, bolstering its expansive Clinical App Collection. With these new and improved apps, the ACC continues to diversify the clinical content and decision support it offers clinicians in the mobile space.

The STS/ACC TAVR In-Hospital Mortality Risk App assists clinicians in determining the predicted in-hospital mortality risk of a patient who is considering TAVR as a treatment option for aortic valve replacement. Clinicians can evaluate a patient's mortality risk and compare it to the national average based on STS/ACC TVT Registry data. This app marks ACC's first effort in building mobile risk applications for the ACC National Cardiovascular Data Registry using NCDR data and is part of ACC's efforts to use NCDR data to improve the quality of cardiovascular care.

The AnticoagEvaluator has been completely redesigned to be more user friendly and offer additional support, including recommendations from the 2013 ACC/AHA/HRS Atrial Fibrillation Guideline. The app helps clinicians make well-informed decisions on antithrombotic therapy for non-valvular atrial fibrillation patients by allowing them to calculate a patient's renal function and risk of ischemic stroke, blood clot and bleed; generate individualized risk for antithrombotic therapy options based on individual clinical trials; and improve accurate use of direct oral anticoagulants with renal-function-adjusted dosage based on prescribing information. The app now also includes Edoxaban on the list of available anticoagulant therapies and the Cockcroft-Gault equation for calculating renal function.

The ACC will continue to expand its Clinical App Collection in 2016 with offerings based on new clinical pathways documents, appropriate use criteria, additional guideline releases, NCDR risk models and other sources. All ACC apps are free and can be found by searching their titles in the iTunes or GooglePlay app stores.

Source: American College of Cardiology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality